WallStreetZenWallStreetZen

NASDAQ: NERV
Minerva Neurosciences Inc Stock Ownership - Who owns Minerva Neurosciences?

Insider buying vs selling

Have Minerva Neurosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Remy LuthringerCEO2023-05-023,641$3.76
$13.69kSell
Frederick W. AhlholmSVP CFO and Secretary2023-05-013,580$4.48
$16.04kSell
Remy LuthringerCEO2023-05-0123,753$3.85
$91.45kSell
Geoff RacePresident2023-05-0122,082$3.85
$85.02kSell

1 of 1

NERV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NERV insiders and whales buy or sell their stock.

NERV Shareholders

What type of owners hold Minerva Neurosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Index Venture Associates Iii Ltd122.83%8,590,095$21.73MInsider
Care Capital Iii LLC79.30%5,545,804$14.03MInsider
Michele Ollier67.08%4,690,906$11.87MInsider
Rubertis Francesco De67.08%4,690,906$11.87MInsider
Lorenzo Pellegrini55.53%3,883,212$9.82MInsider
Johnson Johnson46.96%3,284,353$8.31MInsider
Federated Hermes Inc19.32%1,351,275$3.42MInstitution
Ingelheim International Gmbh Boehringer18.23%1,275,000$3.23MInsider
Barclays PLC8.65%605,230$1.53MInsider
Fmr LLC7.03%491,746$1.24MInstitution

1 of 3

NERV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NERV6.78%93.22%Net Selling
BNTC46.20%28.78%
ORGS4.00%96.00%Net BuyingNet Buying
GLTO14.20%24.86%Net Selling
VAXX4.14%95.86%Net Buying

Minerva Neurosciences Stock Ownership FAQ

Who owns Minerva Neurosciences?

Minerva Neurosciences (NASDAQ: NERV) is owned by 34.54% institutional shareholders, 475.09% Minerva Neurosciences insiders, and 0.00% retail investors. Index Venture Associates Iii Ltd is the largest individual Minerva Neurosciences shareholder, owning 8.59M shares representing 122.83% of the company. Index Venture Associates Iii Ltd's Minerva Neurosciences shares are currently valued at $21.65M.

If you're new to stock investing, here's how to buy Minerva Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.